To assess why superior in vitro performance of L1CAM-LS-28/ζ CAR T cells was not translated into superior anti-cancer activity in vivo, we monitored whether CAR T cell survival differed between the individual CAR T cell subsets after antigen exposure. Here, L1CAM is linked to cancer.